These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4619025)

  • 1. [Clinical therapeutic trials].
    Mathé G
    Bull Cancer; 1974; 61(2):191-212. PubMed ID: 4619025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Common language for expression of therapeutic results in oncology].
    Chauvergne J; Hoerni B; Durand M
    Bull Cancer; 1974; 61(2):235-44. PubMed ID: 4619026
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for the clinical evaluation of antianxiety drugs. HEW (FDA) 77-3043, September 1977.
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):297-312. PubMed ID: 45205
    [No Abstract]   [Full Text] [Related]  

  • 4. Advantages of a unit dose drug distribution system in surveillance of adverse drug reactions.
    Bergman HD; Aoki VS; Black HJ; Dick RW; Leaverton PE; Wilson WR
    Clin Toxicol; 1972; 5(3):405-17. PubMed ID: 5073823
    [No Abstract]   [Full Text] [Related]  

  • 5. On the usefulness of the placebo and of the double-blind technique in the evaluation of psychotropic drugs.
    Tétreault L; Bordeleau JM
    Psychopharmacol Bull; 1971 Jul; 7(3):44-64. PubMed ID: 4940648
    [No Abstract]   [Full Text] [Related]  

  • 6. The randomized clinical trial.
    Ingelfinger FJ
    N Engl J Med; 1972 Jul; 287(2):100-1. PubMed ID: 4555589
    [No Abstract]   [Full Text] [Related]  

  • 7. [Are children in the shadow region of drug therapy].
    Hämäläinen M
    Duodecim; 2001; 117(18):1781-2. PubMed ID: 12181973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principles of selection of control groups in clinical and prophylactic trials].
    Magnus K
    Nord Med; 1969 Nov; 82(47):1465-70. PubMed ID: 4903456
    [No Abstract]   [Full Text] [Related]  

  • 9. Lethal drug interactions.
    Martin EW
    Tex Med; 1973 Jan; 69(1):39-55. PubMed ID: 4631428
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical examination of drugs, a scientific and ethical challenge.
    Mathé G
    Biomedicine; 1973 May; 18(3):169-72. PubMed ID: 4582613
    [No Abstract]   [Full Text] [Related]  

  • 11. How to read clinical journals: V: To distinguish useful from useless or even harmful therapy.
    Can Med Assoc J; 1981 May; 124(9):1156-62. PubMed ID: 7016293
    [No Abstract]   [Full Text] [Related]  

  • 12. [Placebos and double-blind studies: significant differences].
    Schelling JL
    Rev Med Suisse Romande; 1969 Sep; 89(9):905-9. PubMed ID: 4921157
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug reactions and errors in administration on a medical ward.
    Hoddinott BC; Gowdey CW; Coulter WK; Parker JM
    Can Med Assoc J; 1967 Oct; 97(17):1001-6. PubMed ID: 6052897
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-randomized controls in cancer clinical trials.
    Gehan EA; Freireich EJ
    N Engl J Med; 1974 Jan; 290(4):198-203. PubMed ID: 4587632
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled clinical therapy study. Position papers on the contribution by S. Koller: Attack against progress in medicine--contention of illegality of controlled clinical therapy studies in Fortschr, Med. 95, 42:2570 (1977). Misleading the public].
    Fiebig U
    Fortschr Med; 1978 Dec; 96(47-48):2377-8. PubMed ID: 363579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical therapeutic trials: introduction to the topic].
    Buchborn E
    Internist (Berl); 1982 Apr; 23(4):183-6. PubMed ID: 7045019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations for improving the predictive value of phase I to III data concerning the clinical and biological tolerance of a new drug].
    Auriche M
    Therapie; 1987; 42(4):335-7. PubMed ID: 3686466
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of desired and undesired effects of prolonged drug administration].
    Bogaert M
    Verh K Acad Geneeskd Belg; 1980; 42(5-6):233-41. PubMed ID: 7257562
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug trials. Reform or modification of the current system].
    Lemaire A
    Nouv Presse Med; 1975 May; 4(18):1367-71. PubMed ID: 1098017
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal requirements for drug testing in children in Germany.
    Hasskarl H
    Pediatr Pharmacol (New York); 1983; 3(3-4):361-6. PubMed ID: 6677882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.